The e f f e c t of deoxynucleosides on s i n g l e strand chromosomal breaks i n peripheral blood lymphocytes (PBL) were measured both by t h e sucrose gradient nucleoid sedimentation method and by alk a l i n e unwinding followed by f l u o r i m e t r i c measurement of etidium bromide binding t o double stranded DNA. E x t r a c e l l u l a r deoxyadenosine (0.3-10 pM) i n the presence of deoxycoformycin (1 vM) cause extensive DNA damage i n PBL i n a concentration dependent manner. The appearance of DNA damage following deoxyadenosine a d d i t i o n t o PBL c o r r e l a t e d with t h e accumulation of i n t r a c e l lu l a r dATP l e v e l s . E x t r a c e l l u l a r deoxycytidine (50 pM) i n h i b i t e d t h e accumulation of i n t r a c e l l u l a r dATP from deoxyadenosine and i n p a r a l l e l prevented t h e DNA damage caused by deoxyadenosine i n PBL. On t h e other hand, a d d i t i o n of e x t r a c e l l u l a r deoxyguanos i n e (50 pM) o r thymidine (50 LIM) a l s o completely prevented t h e DNA damage by deoxyadenosine but without i n t e r f e r r i n g with dATP accumulation. Measurements of i n t r a c e l l u l a r deoxynucleoside triphosphates l e v e l s i n PBL show extremely low l e v e l s of dGTP, dCTP and TTP and higher l e v e l s of dATP. I t i s possible t h a t the marked increase of i n t r a c e l l u l a r dATP l e v e l s combined with the extremelylow l e v e l s of the o t h e r deoxynucleoside triphosphates i n t e r f e r with DNA r e p a i r process i n r e s t i n g PBL r e s u l t i n g i n the appearance of s i n g l e stranded breaks. Thymocytes, which contain higher l e v e l s of deoxynucleoside triphosphates, d i d not show DNA damage i n the presence of deoxyadenosine. Though c y c l i c GMP (cGMP) has been s t r o n g l y implicated i n morphine's a n a l g e t i c a c t i o n , t h e r e l a t i o n s h i p between pharmacologic a c t i v i t y of morphine and brain l e v e l s of cGMP i s not y e t well understood. Here, we investigated e f f e c t s of morphine on cGMP metabolism. Brain s l i c e s were incubated i n tonometer a t 37OC with Krehs-Ringer bicarbonate/glucose buffer, pH 7.35, constant flow of 02/C02 (20: 5) and 2.90 x 10" mM of s u b s t r a t e cGMP o r 5'-GMP. Sequentially withdrawn a l i q u o t s of incubation mixture were analyzed by HPLC. Control brain s l i c e s yielded primary metabolic products, GMP, guanosine (GUS), guanine, xanthine, and inosine. Accumulation of guanosine agreed with evidence demons t r a t i n g t h a t nucleoside phosphorylase i s r a t e limiting. Chromatographic findings of inosine from samples of human brain s l i c e s incubated with cGMP o r 5'-GMP a s s u b s t r a t e extended our e a r l i e r r e p o r t of 5'-GMP reductase a c t i v i t y i n r a t brain. No u r i c acid was detected. Morphine (1.46 x mM) s i g n i f i c a n t l y reduced r a t e of cGMP and 5'-GMP metabolisms r e s u l t i n g i n l a t e n t GUS accumulalion s u b s t a n t i a l l y increased over control values. Our data suggest t h a t morphine a l t e r s purine metabolism by i n h i b i t i n g cGMP phosphodiesterase and 5'-nucleotidase. This may ultimately a s s i s t i n e s t a b l i s h i n g both biological significance of cGMP metab o l i t e s and multiple a c t i o n s of morphine on t h e central nervous system. Supported by NIH/MBRS Grant RR 0809-12. Cytosolic 5'-nucleotidase from r a b b i t h e a r t has been p u r i f i e d approximately 40-fold t o a s p e c i f i c a c t i v i t y of 0.6 umolfmg proteinjmin. A t t h i s s t a g e of p u r i f i c a t i o n , t h e enzyme is f r e e of o t h e r phosphatases and is s t a b l e t o repeated cycles of f r e e z i n g and thawing over a 3 months period. Soluble 5'-nucleotidase has an absolute requirement f o r d i v a l e n t metal i o n s and i s a c t i v a t e d by ATP, GTP, and ADP. Activation by t h e s e nucleotides causes a s h i f t from a sigmoidal t o a hyperbolic s u b s t r a t e s a t u r a t i o n curve. ATP (1 mM) i n c r e a s e s t h e Kapp of t h e enzyme f o r AMP about 5-fold. Activation by GTP i s s i m i l a r . Activation by ADP a l s o increases Kapp, but high concentrations of ADP cause a decrease i n Vmax.
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AMP i s t h e preferred s u b s t r a t e i n terms of Vmax/Ka p, with AMP>UMP>GMP>IMP. Nucleoside monophosphates o t h e r tEan AMP a r e i n h i b i t o r y a t high s u b s t r a t e concentrations. The f u l l y a c t i v a t e d enzyme e x h i b i t s a Kapp f o r AMP of 2.5 mM. The enzyme p u r i f i e d by u s has p r o p e r t i e s d i f f e r e n t from t h e soluble l i v e r enzyme described by Van Den Berghe e t a l . (Biochem. J. (1977) 162, 611) and from t h e plasma membrane enzyme from rat h e a r t described by Naito & Lowenstein (Biochem. (1981) 0, 5188) with respect t o both s u b s t r a t e s p e c i f i c i t y and regulatory properties.
ELEVATED ERYTHROCYTE ADENOSINE DEAMINASE (ADA) ACTI-

41) VITY I N ACQUIRED IMMUNODEFICIENCY DISEASE (AIDS)
. -Morton J. Cowan and Kenneth J. Widder, u n i v e r s i t y of California, School of Medicine, Department of P e d i a t r i c s , San Francisco and Molecular Biosystems, Inc, San Oieqo, CA USA AIDS i s an o f t e n f a t a l disease thouqht t o be caused by a r e t r ov i r u s (LAV) frequently r e s u l t i n q i n maliqnancy such a s Kaposi's sarcoma (KS) and/or o p p o r t u n i s t i c i n f e c t i o n (01). One AIDS rel a t e d disease is lymphadenopathy syndrome (LAS) which may proqr e s s t o KS o r 01. Because t h e immune deficiency i n AIDS is simi l a r t o t h a t i n some purine enzyme d e f i c i e n c i e s we measured e r y t h rocyte ADA and purine nucleoside phosphorylase (PNP) a c t i v i t i e s (nm/mgHg/hr).in p a t i e n t s with AIDS, heterosexual c o n t r o l s (CONT) and a high r i s k asymptomatic population (RISK). ADA was s i a n i fc a n t l y elevated i n t h e AIDS p a t i e n t s and i n 5/11 RISK p a t i e n t s while PNP was normal (mean t SD):
CONT We evaluated t h e e f f e c t s of recombinant DNA IL-2, a T-cell lymphokine which i s e s s e n t i a l f o r normal immune function on t h e responses t o mitogen and alloantigen of peripheral blood mononuclear c e l l s (PBMC) from 3 ADA d e f i c i e n t p a t i e n t s . There was s i g n i f i c a n t enhancement by IL-2 of mitogenic responses t o phytohemagglutinin (PHA), pokeweed mitogen (PWM) and alloantigen (MLR) in a l l 3 p a t i e n t s . Patients with ADA p o s i t i v e severe combined immunodeficiency disease showed no responses t o IL-2: 
----
To determine t h e responsive c e l l population we measured T3, T4
and T8 expression in PBMC exposed t o PHA + IL-2. Normal PBMC respond with increased T3 c e l l s but no change i n T4 o r T8 expression. The ADA d e f i c i e n t PBMC incubated with an ADA i n h i b it o r , deoxyadenosine and PHA cannot be salvaged by IL-2. These r e s u l t s demonstrate a unique f e a t u r e of t h e immunodeficiency i n ADA deficiency and provide f u r t h e r evidence t h a t purine metabolism is d i s t i n c t i n lymphocyte subsets. Also, t h e standard 5 v i t r o c e l l m d e l of ADA deficiency may he s i q n i f i c a n t l y l i m i t e d i n s use i n understanding t h e pathogenesis of t h i s disease. Medical C e n t e k a r t m e n t of Internal Meii:int Ann Arbor!MI, USA. ~ssociated with an autosanal recessive form of severe combined immunodeficiency disease, while subjects with partial enzyme activity a r e immunocompetent. To further our understanding of ADA deficiency, specific mRNA levels and rates of protein turnover were determined in partial ADA deficient cells and enzyme expression of cloned human ADA cDNA was assessed. Genetic expression of ADA in cultured B lymphoblast cell lines from 4 partially (5-50% activity) ADA deficient subjects showed norm01 t o 2-fold normal ADA mRNA levels (Northern blot). Among these cell lines enzyme synthesis varied from 165% t o 15% of normal. ADA degradation rates were 1.5 t o almost 3 times faster than normal, consistent with the complete absence of t h e enzyrne in patient erythrocytes. Cloned normal human ADA cDNA inserted into an SVbO based expression vector was shown t o generate human ADA activity In monkey kidney (COS) host cells (7-fold over host). An vnexpected finding was t h e identification of another normal human ADA cDNA construct which failed t o prodlice human ADA activity or immunoreactive protein upon transfection. DNA sequence analysis revealed a single nucleotide substitution within this clone that altered the predicted sequence of ADA protein a t amino acid 50.
Thus, our studies define transcriptional, translational and posttranslational defects in partial ADA deficiency and identify a point mutotion in ADA cDNA which mimics the phenotype expressed in severe ADA deficiency.
